10X Capital Venture Acquisition Corp. III: Nasdaq/NYSE listing notice — 10X Capital Venture Acquisition III cures NYSE American listing non-compliance by filing Q3 10-Q

10X Capital Venture Acquisition Corp. III

Received NYSE American notice on Nov 21 for late Q3 2023 Form 10-Q due Nov 20.
Cure period of six months; company filed the Q3 10-Q on Nov 27, 2023, curing non-compliance.
No immediate effect on listing of VCXB units, Class A shares, or warrants.
Delay attributed to auditor completing review of Q3 financial statements.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

10X Capital Venture Acquisition Corp. III received a nyse_american noncompliance notice notice regarding late filing.

Exchange: nyse american
Notice: noncompliance notice
Deficiency: late filing

Exact text from the filing

November 21, 2023, 10X Capital Venture Acquisition Corp. III, a Cayman Islands exempted company (“10X III”), received a written notice (the “Notice”) from New York Stock Exchange Regulation, Inc. indicating that 10X III was not in compliance with the NYSE American LLC’s (“NYSE American”) continued listing standards because 10X III did not timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Quarterly Report”), which was due on November 20, 2023. The Notice provided that 10X III had a period of six months from the original due date of the Quarterly Report

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001213900-23-090570

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.